Legal Representation
Attorney
Eric Lamb
USPTO Deadlines
Next Deadline
1304 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230718)
Due Date
July 18, 2029
Grace Period Ends
January 18, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
29 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 18, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 18, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 16, 2023 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jun 15, 2023 | FIXD | O | ELECTRONIC RECORD REVIEW COMPLETE | Loading... |
| Jun 15, 2023 | FIXD | O | ELECTRONIC RECORD REVIEW COMPLETE | Loading... |
| Jun 9, 2023 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | Loading... |
| Jun 9, 2023 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jun 8, 2023 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jun 2, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jun 1, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| May 5, 2023 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jun 1, 2023 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| May 5, 2023 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| May 30, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| May 5, 2023 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| May 5, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Nov 8, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 13, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 13, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 24, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 9, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 28, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jun 28, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 28, 2022 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 28, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 22, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 23, 2021 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Oct 22, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 22, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 040
Custom assembling of materials for others; custom manufacturing of pharmaceuticals; custom manufacturing of drug conjugates; custom production of pharmaceuticals; custom production of biological preparations; custom manufacturing of antibody-drug conjugates; custom manufacturing of chemical reagents; custom manufacturing of pharmaceutical preparations; custom manufacturing of biomedical preparations; custom manufacture of drug conjugates
First Use Anywhere:
20210700
First Use in Commerce:
20210900
Class 042
Development of products for others; pharmaceutical drug development services; research and development of new products; biochemical research and development; custom design and development of chemical reagent antibodies and conjugate antibodies; research and development in the pharmaceutical, biomedicine and biotechnology fields; research and development of antibodies; research and development of conjugated antibodies; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibody-drug conjugates; research and development of drug conjugates
First Use Anywhere:
20210700
First Use in Commerce:
20210900
Additional Information
Design Mark
The mark consists of the stylized wordings "WUXI" over "XDC", partially inside an incomplete oval outline that intersects with another incomplete oval outline. Below these appears the wording "THE BIOCONJUGATION LEADER" in stylized font.
Classification
International Classes
040
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"WUXI" OR "BIOCONJUGATION"